Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2022 | Challenges in treating PV and optimal management strategies

Raajit Rampal • 26 Aug 2022
Texas MPN Workshop 2022
Myeloproliferative Neoplasms Polycythemia Vera Rare Diseases

Raajit Rampal, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, highlights challenges in treating polycythemia vera (PV), drawing focus on the importance of recognizing and controlling symptoms. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

More from Raajit Rampal

Fibrotic progression of ET and PV: clinical and biological considerations
Raajit Rampal • 24 Nov 2022
1:00
How genomic testing has influenced treatment approaches and clinical trial design in MPNs
Raajit Rampal • 26 Aug 2022
1:05
Venetoclax-based combinations in patients with accelerated and blast-phase MPNs
Raajit Rampal • 26 Aug 2022
0:46
The prognostic impact of TP53 mutation in MPNs
Raajit Rampal • 26 Aug 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals